FDA Warning Letter — The HCG Institute

Case 716512 — FEI 3040107385

The FDA took a Warning Letter action against The HCG Institute on Sep 9, 2025 (Medford, NJ). The action was issued by CDER and concerns drugs products.

Action details

Facility
The HCG Institute
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Medford, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.